Big Rock Partners Acquisition Corp. (NASDAQ:BRPA) filed an 8-K this afternoon showing that its shareholders had approved extending its transaction deadline to April 23, 2021.
Additionally, Big Rock tallied zero redemptions in connection with the move, despite what would normally be an attractive redemption rate of $10.78.
Four days ago, Big Rock announced a definitive combination agreement with NeuroRx. It is a biopharmaceutical firm working to secure regulatory approval for a potential COVID-19 therapy that could increase recovery times from respiratory failure.
This news pushed the company’s stock up to $13.79 on the morning of its redemption deadline and it opened today at $15.70. However, being fairly “low-float” might have been a contributing factor.
Big Rock initially listed in November 2017, and as such has had to extend its deadline five times before, resulting in 92% of its original shares redeeming. It has structured its deal with NeuroRx with an incentive structure strongly tied to it crossing regulatory benchmarks with its COVID-19 treatment.
For a full description of measures on the ballot and vote tallies, click HERE.
EQV Ventures II (NYSE:EVACU) has filed for a $350 million SPAC aiming to give its team a second vehicle to pursue targets within hopefully a more receptive market environment than its first. The team’s first SPAC, EQV I (NYSE:EQV), broke price on its debut on August 7, 2024, finishing with a one-day VWAP of $9.9452...
HCM III (NASDAQ:HCMAU) has filed for a $220 million SPAC to mount a broad search for a target with a team that had been steadily building a track record of success. The new SPAC offers investors a 1/3 warrant in each unit, but no overfunding of its trust as the team has done in its...
At the SPAC of Dawn Although the past month has been busy in many forms of SPAC activity, it has so far marked a slowdown from April in terms of new deal announcements with three in May and two so far in June. There are several signs that more are on the way, however, including...
Cantor Equity III has filed for a $200 million SPAC to keep Cantor’s hot streak going. The new SPAC is to be warrantless like its predecessors, selling only shares in its offering, which would normally create a steeper hill to climb to get investors on board, but the SPAC has a few extra things going...
At the SPAC of Dawn Not all of the big policy decisions made in the first six months of the renewed Trump presidency have been wind under the wings of de-SPACs, but one group of companies in which de-SPACs predominate got a big boost this week. Electric vertical takeoff and landing (eVTOL) plane developers had...